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a b s t r a c t
Kaposi’s sarcoma-associatedherpesvirus (KSHV) is theaetiologic agentofKaposi’s sarcoma (KS), a tumour
of endothelial cell origin. The study of KS developmentwas aided by the generation of a recombinant GFP
(latent)/RFP (lytic)-expressing KSHV (rKSHV.219) byVieira andO’Hearn (2004). In this study the ﬁrst data
characterising primary endothelial cell infection and transmission with this virus is presented. Infection
waspredominantly latent and thepercentageofGFP-positive cells increasedover time.Neitherhorizontaleywords:
ndothelial cell
aposi’s sarcoma-associated herpes virus
kshv.219
transmissionof infection, nor cellular proliferation, explained this increase. Analysis of latency-associated
nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP
expression early post infection. At later time points GFP correlatedmore closelywith LANA-1 expression,
likely due to the accumulation of GFP over time. This study providesmethodological guidance for the use
of rKSHV.21. In addition, it highlights potential problems associated with the use of ﬂuorescent proteins
as markers of viral infection.. Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the aeti-
logic agent of Kaposi’s sarcoma (KS), a multifocal malignancy
haracterised by spindle-shaped tumour cells with an endothelial
henotype (Ganem, 2006). KS is currently the leading malignancy
ssociated with acquired immunodeﬁciency syndrome (AIDS) and
ndemic KS is a cause of high morbidity and mortality in parts
f Africa (Mesri et al., 2010). Historically, most in vitro studies
f the consequences of KSHV infection of endothelial cells have
sed concentrated virus from supernatants of primary effusion
ymphoma cultures, which had been induced into lytic replication
sing phorbyl myristate acetate. Although cell lines can be readily
nfected with KSHV produced in this way, primary endothelial
ells are less susceptible, with some reporting very low (<10%)
SHV infection rates using standard protocols (Ciufo et al., 2001;
lore et al., 1998). Others achieved higher infection rates with the
 This is an open-access article distributed under the terms of the Creative
ommons Attribution License, which permits unrestricted use, distribution and
eproduction in any medium, provided the original author and source are credited.
∗ Corresponding author. Present address: Department of Medicine, Centre for
olecular Medicine, Karolinska Institute, Stockholm 171 76, Sweden.
el.: +46 8 517 79896.
E-mail address: Lynn.Butler@ki.se (L.M. Butler).
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ttp://dx.doi.org/10.1016/j.jviromet.2013.06.001© 2013 Elsevier B.V. All rights reserved.
aid of the antiheparin reagent, polybrene (DiMaio et al., 2011),
but at the expense of possible off target effects. Thus, it is impor-
tant to be able to identify KSHV-infected endothelial cells from
uninfected endothelial cells within the inoculated population,
particularly when infection rates are low. However, endothelial
cells infected with primary effusion lymphoma cell-derived KSHV
cannot be readily distinguished from uninfected endothelial cells
without staining for KSHV antigens (such as the nuclear expressed
latency-associated nuclear antigen, LANA-1). To circumvent this
inconvenience, and to also allow a platform for genetic manipu-
lation of KSHV, Vieira and O’Hearn generated a novel recombinant
KSHV (rKSHV.219), propagated in the primate Vero cell line. This
virus was constructed using KSHV from the JSC-1 primary effusion
lymphoma cell line and was engineered to expresses the green
ﬂuorescent protein (GFP) gene from the EF-1 promoter, as a
marker of latent infection, and the red ﬂuorescent protein (RFP)
gene from the PAN RNA promoter, as a lytic cycle marker (Vieira
andO’Hearn, 2004). The generation of this recombinant virusmade
the identiﬁcation of ‘rKSHV.219-infected’ cells (GFP-positive) and
‘rKSHV.219 lytic’ cells (RFP-positive) very convenient. For these
reasons many groups, including our own, have used rKSHV.219
to study the consequences of KSHV-infection on endothelial cells
and other cell types.
This study describes the infection dynamics of rKSHV.219 in
primary endothelial cells (isolated from human umbilical veins)
and evaluates the validity of using GFP as a deﬁnitive marker
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f infection. In the system, the peak in RFP-positive, lytic cells
ccurred early after inoculation and the percentage of GFP-positive
ells in rKSHV.219-inoculated cultures increased over time. Impor-
antly, this increase in GFP-positive cells was not due to the
nduction of infected cell proliferation. Neither was it caused by
ransmission of the virus from the lytically infected to the unin-
ected cells within the population. Instead, the observations in
his study suggested that the temporal increase in percentage
FP-positive cells within inoculated cultures was due to the accu-
ulation of cellular GFP over time, rather than de novo infection.
oreover, this study identiﬁed that at early time points post-
noculation GFP-negative endothelial cells could be positive for
ANA-1; thus it highlighted a discrepancy between the two alter-
ative systems for detection of infection that this model provides
percentage GFP-positivity and positivity for a KSHV latency pro-
ein such as LANA-1). GFP-negative, LANA-1 positive endothelial
ells had a lower number of LANA-1 dots than those that were
FP-positive, suggesting that a threshold level of infection was
ecessary for GFP expression to reach detectable levels. Greater
oncordance between LANA-1 and GFP expression was noticed at
ater times post-inoculation, indicating that GFP became a more
eliable marker of infection over time.
Overall, this report provides important guidance for the use
f rKSHV.219 in studies of primary endothelial cell infection
ith KSHV. In addition to their importance in the context of the
nterpretation of experimental results acquired using rKSHV.219,
hese observations highlight potential problems when using GFP
xpressed from a cellular promoter as a deﬁnitive marker of viral
nfection at early time points. In addition, this study highlights
ssues that should also be considered in the context of other recom-
inant viruses that have been similarly engineered to express
uorescent proteins asmarkers of infection. Furthermore, it reveals
he heterogeneity of primary endothelial cells for infection with
KSHV.129 and provides novel insights into the biology of KSHV
ellular dissemination within primary endothelial cell cultures.
. Materials and methods
.1. Production of rKSHV.219 from VK219 cells
rKSHV.219 was produced from the latently infected Vero cell
ine, VK219. VK219 cells were maintained at 37 ◦C, 5% CO2 in
EM medium (Sigma, Poole, UK) supplemented with 10% foetal
ovine serum (FBS; PAA Laboratories, Yeovil, UK), 2.2 g/L NaHCO3,
g/ml puromycin (both Sigma), 10U/ml penicillin and 10g/ml
treptomycin (both Invitrogen, Life Technologies, Carlsbad, CA). For
KSHV.219 production, VK219 were plated to yield 60% conﬂuence
nd infected with Baculovirus K50 (BacK50) with 1.25mM sodium
utyrate (Sigma), to induce lytic replication. BacK50 is a recom-
inant baculovirus engineered to express the KSHV lytic switch
eplication and transcription activator (RTA) protein, encoded by
RF50 (Vieira and O’Hearn, 2004). BacK50 was produced in insect
F9 cells maintained at 28 ◦C, 5% CO2 in Sf-900 II medium (Invit-
ogen) supplemented with 10% FBS (PAA Laboratories), 50U/ml
enicillin and50g/ml streptomycin (both Invitrogen). For BacK50
roduction, SF9 cells were expanded to 2×106 cells/ml and inoc-
lated with BacK50. At 3 days post-inoculation (dpi), supernatants
ere separated from SF9 cells by centrifugation at 450× g for
0min, ﬁltered through a 0.45m ﬁlter and stored at 4 ◦C. 48h
ollowing BacK50-induced reactivation, VK219 cell supernatants
ere collected and centrifuged at 500× g for 15min, to remove
ell debris, then ultracentrifuged at 31,000× g, 4 ◦C for 4h. The
esultant rKSHV.219 pellet was re-suspended overnight in EBM2
edium (Lonza, Clonetics, Anaheim, CA, USA).We tested the effect
f storage temperature (4 ◦C or −80 ◦C) on rKSHV.219 infectiousl Methods 193 (2013) 251–259
titre. Oneweek post-production therewas no effect of storage tem-
perature on infectious titre. However, after 3–4 weeks we noticed
that storage at −80 ◦C tended to reduce infectious titre compared
to storage at 4 ◦C (supplementary Figure 1). Therefore, rKSHV.219
preparations were subsequently stored at 4 ◦C prior to use.
2.2. Determination of rKSHV.219 titre
Approximate infectious titre of rKSHV.219 was determined
using a standardised protocol of titration on HEK293 cells. HEK293
cells were maintained at 37 ◦C, 5% CO2 in Dulbecco’s Modiﬁed
Eagle Medium (Gibco, Invitrogen) supplemented with 10% FBS
(PAA Laboratories), 2mM glutamine, 50U/ml penicillin, 50g/ml
streptomycin (all Invitrogen) and 1% non-essential amino acids
(Sigma). HEK293 were plated at 2.0×104 cells/96-well then cul-
tured overnight before serial dilutions of rKSHV.219, diluted in
EBM2 medium, were added and the plates centrifuged at 330× g
for 30min. The medium was changed after 90min and the number
of GFP-positive cells per well was quantiﬁed 48h later. The titre
was calculated (infectious units/ml), assuming that one infectious
unit generated one GFP-positive HEK293. We found a reduction in
rKSHV.219 infectious titre over extended storage time (supplemen-
tary Figure 2). Therefore, the infectious titres of preparations were
re-determined if they were not used within 3 weeks of production.
2.3. Isolation and culture of human umbilical vein endothelial
cells
Primary endothelial cellswere isolated fromumbilical cords and
cultured in Medium 199 (Gibco, Invitrogen) supplemented with
20% FBS, 2.5g/ml amphotericin B, 50U/ml penicillin, 50g/ml
streptomycin, 1ng/ml EGF, 28g/ml gentamycin and 1g/ml
hydrocortisone (all Sigma). Primary cultures were dissociatedwith
trypsin/EDTA (Sigma) and passaged into tissue culture multi-well
plates (Falcon; Becton Dickinson Labware, Oxford, UK) or pre-
fabricated channel slides (-SlideVI) (Ibidi,Martinsried, Germany).
Seeding density yielded conﬂuent monolayers for infection within
24h, unless otherwise stated. Each experiment used a separate
endothelial cell donor.
2.4. Infection of endothelial cells with rKSHV.219
rKSHV.219wasdiluted inEBM2 (Lonza, Clonetics) to give appro-
priate infectious units/ml prior to addition to endothelial cells at a
multiplicity of infection (MOI) of between 1 and 10. Inoculated cells
were centrifuged at 450× g for 30min (untreated samples were
treated in an identical manner, except there was no addition of
virus). Endothelial cellswere incubated for a further90minat37 ◦C,
5%CO2 before inoculumwas replacedwithM199 and supplements.
rKSHV.219-inoculated and untreated endothelial cells are denoted
as rKSHV.219-EC and UT-EC, respectively in the ﬁgures.
2.5. Determining the percentage of GFP-positive,
rKSHV.219-infected cells within inoculated endothelial cell
cultures
Cultures of untreated and KSHV.219-inoculated endothelial
cells were dissociated with trypsin-EDTA (Sigma) and ﬁxed in 2%
formaldehyde (Sigma). The GFP ﬂuorescence intensity of each cul-
ture was analysed on a Dako Cyan ﬂow cytometer. A minimum of
3000 events was counted. Data were analysed using FlowJo (Tree
Star, OR, USA) or Dako Summit 4.3 (Dako, Stockport, UK) software.
Cells were considered GFP-positive if they had a GFP ﬂuorescence
intensity greater than that of 99% of untreated cells.
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et al., 1999). In order to investigate if this was true for rKSHV.219
infection of endothelial cells, monolayers of varying cell densities
between sub- and fully conﬂuent were treated with the virus and
Fig. 1. Effect of rKSHV.219 MOI and conﬂuence on GFP expression. (A) Endothelial
cells were inoculated with rKSHV.219 at multiplicities of infection (MOI) between
1.25 and 10 and cultured for a further 10 days, before the percentages of GFP-
positive cells were measured by ﬂow cytometry (*P<0.05; ***P<0.001 compared
to MOI1.25 and +P<0.05 compared to MOI 2.5). (B) Endothelial cells were platedH.C. Jeffery et al. / Journal of Viro
.6. Immunocytochemistry for LANA-1 expression
Endothelial cells were ﬁxed in 4% formaldehyde, permeabilised
ith methanol and blocked with PBS/goat serum (5%) (Sigma).
rimary antibody against LANA-1 (unconjugated rat anti-LANA,
dvanced Biotechnologies, Columbia, USA) was added and incu-
ated overnight at 4 ◦C then conjugated secondary antibody (Alexa
luor 633-conjugated anti-rat IgG, Invitrogen)was added for 1–2h.
isbenzimide (Sigma) was used as a nuclear stain and channels
ere coated with ProLong Gold anti-fade mountant (Invitrogen)
rior to visualisation. Imageswere capturedon aZeiss LSM510 con-
ocalmicroscope and analysed using ImageJ software. For each cell,
he number of LANA-1 dots and its GFP status was recorded.
.7. Assay for the effect of rKSHV.219-inoculation upon
ndothelial cell density over time
Endothelial cells were plated in pre-fabricated channel slides
-slides VI; Ibidi), cultured overnight and then inoculated with
KSHV.219 at MOI10. At time points up to 10dpi, cultures were
bserved using a 4× objective lens and phase contrast, GFP ﬂuores-
ence (signifying latent infection) and RFP ﬂuorescence (signifying
ytic infection) imageswere taken. After imaging,monolayerswere
ashed four times with complete medium and images retaken so
hat the number of lytic cells not removed by washing could be
ubtracted from the number observed at the next time point and
he extent of lytic reactivation between time points calculated. The
umulative evolution of lytic cells was also calculated by summing
henumbers generatedbetween timepoints. Theviable cell density
as determined from the phase contrast images.
.8. Assay to examine horizontal transmission of infection
hrough rKSHV.219-inoculated endothelial cell monolayers
To determine if rKSHV.219 was transmitted horizontally
hrough endothelial cell monolayers, rKSHV.219-inoculated cells
ere co-cultured with untreated cells that had been labelled with
he far-red ﬂuorescent tracer DDAO-SE (Invitrogen). rKSHV.219
ransmission to untreated cells could be identiﬁed by dual ﬂuores-
ence forGFP andDDAO-SE. For the assay, threepopulations of cells
rKSHV.219-inoculated non-labelled; untreated non-labelled and
ntreated DDAO-SE labelled) were detached from the inoculation
late at the time point of interest, either 5h or 3dpi, and re-plated
n a 48-well plate either as mono-cultures or as 1:1 co-cultures
ncluding: (i) untreatedDDAO-SE labelled +untreated non-labelled
nd (ii) untreated DDAO-SE labelled + rKSHV.219-inoculated non-
abelled. Aliquots of each cell suspension were transferred to
ACS tubes at the start of the co-culture period and ﬁxed in
% formaldehyde for assessment of the starting/background per-
entages of each cell type which included: rKSHV.219 inoculated
ut non-infected (DDAO-SE negative/GFP negative); rKSHV.219
noculated infected (DDAO-SE negative/GFP-positive); untreated
ninfected (DDAO-SE positive/GFP negative); untreated infected
DDAO-SE positive/GFP-positive). After 5 days of co-culture, cells
ere detached and ﬁxed in 2% formaldehyde (Sigma) for analysis
f the extent of transmission by ﬂow cytometry.
.9. Statistics
Parametric statistical tests were performed using GraphPad
rism 5.0a following testing to conﬁrm that data were normally
istributed using the Kolmogorov–Smirnov test. Unless otherwise
tated in the ﬁgure legends, effects of treatmentswere tested using
nalysis of variance (ANOVA) followed by the Dunnett’s multiple
omparison or Bonferroni post hoc tests. Unpaired t-tests or paired
-tests as appropriate were used to compare characteristics of cellsl Methods 193 (2013) 251–259 253
found in two different populations or at two different time points.
Error bars on graphs represent the standard error of the mean
(SEM).
3. Results
3.1. Infection of endothelial cell cultures with rKSHV.219
In order to determine the effect of virus copy number on the
percentage of GFP-positive cells within cultures of rKSHV.219-
inoculated endothelial cells, rKSHV.219 was added at different
multiplicities of infection (MOI), and thepercentageofGFP-positive
cells determined at 10dpi using ﬂow cytometry. The number of
GFP-positive cells increased with MOI (Fig. 1A); therefore, a MOI
of 10 was used in all subsequent experiments to ensure maximal
infection. Previous studies have often publishedmethods inoculat-
ing sub-, rather than fully conﬂuent, cell monolayers with KSHV,
presumably due to the widely held assumption that infection of
cellswithviruses ismoreefﬁcientunder theseconditions (Billstrom
et al., 1999; Ciufo et al., 2001; DeMarchi and Kaplan, 1977; Mosesat densities between 2.5 and 7.5×104 cells/95mm2, inoculated with rKSHV.219
(MOI10) and cultured for a further 7 days, before the percentages of GFP-positive
cells were measured by ﬂow cytometry. Data are expressed relative to the lowest
density tested (*P<0.05; **P<0.01 compared to a density of 2.5×104 cells/95mm2).
Data are mean± SEM for 3–6 independent experiments.
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he percentage of GFP-positive cells assessed at 7dpi. Interestingly,
nfection was least efﬁcient in the most sparsely seeded mono-
ayer, and therewas no difference in the percentage of GFP-positive
ells between the other densities tested (Fig. 1B). All subsequent
xperiments were performed using a cell number that gave a fully
onﬂuent monolayer at the time of inoculation.
.2. Characterisation of rKSHV.219 GFP and RFP expression in
ndothelial cells
To characterise the temporal development of rKSHV.219
nfection within endothelial cell monolayers, phase contrast,
FP and RFP images of untreated and rKSHV.219-inoculated
ultures were taken at various time points up to 10dpi and
rom these images, the viable and RFP-positive (lytic) cell num-
ers were determined. The percentage of GFP-positive cells
as assessed by ﬂow cytometry. Untreated endothelial cells
aintained characteristic cobblestone morphology throughout
Fig. 2). In contrast, by 3dpi some GFP-positive cells within the
KSHV.219-inoculated cultures had an elongated spindle shape
nd the number of GFP-positive cells with this alteredmorphology
ncreased over time (Fig. 2). The percentage of GFP-positive cells
ncreased temporally, from around 30% at 1dpi to 80% by 10dpi
Fig. 3A). Conversely, the maximum presence of RFP-positive lytic
ells occurred around 2dpi, and the extent of lytic reactivation sub-
equently declined to baseline levels (Fig. 3B). Approximately 15%
f cells within the rKSHV.219-inoculated cultures died due to lytic
eath in the ﬁrst 2.5 days. To investigate if the temporal increase
n GFP-positive cells within rKSHV.219-inoculated cultures could
e due to the enhanced replication of the rKSHV.219-infected
ells compared to the uninfected cells, the cell densities of the
ntreated and rKSHV.219-inoculated endothelial cell monolayers
ere counted from the phase contrast images at time points
rior to, and up to 10 days after inoculation (Fig. 3C). Densities of
ntreated monolayers increased up to 24h post-seeding, before
ig. 2. Effect of time post rKSHV.219-inoculation on cell morphology, GFP expression an
MOI 10). Phase contrast, GFP and RFP ﬂuorescence images were taken up to 10dpi. The pl Methods 193 (2013) 251–259
reaching a plateau, whereas rKSHV.219 inoculation caused a
progressive decrease in monolayer density from 12hpi, such that
rKSHV.219-inoculated monolayers were signiﬁcantly different in
density compared to those of untreated control cultures by 1dpi
(Fig. 3C). To assess whether the lower monolayer density with
inoculation was due to the loss of rKSHV.219-infected cells that
underwent lytic replication, the numbers of RFP-positive cells that
evolved between time points (Fig. 3B) were summed to give, for
each time point, the total number of cells that had undergone lytic
replication since the time of inoculation (Fig. 3D). Addition of this
proﬁle to the viable cell density (open diamonds, Fig. 3D) for the
inoculated cultures gave the theoretical total monolayer density
for these cultures (open squares, Fig. 3D). Since total monolayer
density did not equal the density of the untreated control at
4.5 dpi and beyond, the lower densities of the inoculated cultures
could not be completely explained by lytic death. However, the
total densities of the rKSHV.219-inoculated cultures at 0dpi and
8.5dpi were not signiﬁcantly different (P<0.05 by paired t-test).
Thus there was no loss of cell number within the inoculated
monolayers that was not explained by lytic death. Therefore,
the higher numbers of viable cells in the uninfected monolayers
were most probably a consequence of inhibition of proliferation
in monolayers inoculated with rKSHV.219. Since the cell number
associated with rKSHV.219-inoculted cultures did not increase
over time, even as lytic reactivation subsided, it was concluded
that rKSHV.219-inoculation did not induce endothelial cell prolif-
eration. Therefore, proliferation did not account for the increase in
GFP-positive cells in rKSHV.219-inoculated cultures over time.
3.3. Characterisation of rKSHV.219 transmission through
endothelial cell culturesNext, this study sought to determine if the temporal increase
in GFP-positive cells in rKSHV.219-inoculated endothelial cell
cultures was due to horizontal transmission of virus to previously
d RFP expression. Endothelial cells were untreated or inoculated with rKSHV.219
anel shows representative images of 3 independent experiments.
H.C. Jeffery et al. / Journal of Virological Methods 193 (2013) 251–259 255
Fig. 3. Effect of time on GFP and RFP expression and monolayer density in rKSHV.219 inoculated cultures of endothelial cells. Endothelial cells were untreated (UT-EC)
or inoculated with rKSHV.219 (MOI 10) (rKSHV.219-EC) and maintained in culture for analysis of percentage of: (A) GFP-positive cells, (B) RFP-positive cells (*P<0.05 or
**P<0.01 for comparison to 1 or 0dpi respectively in Dunnett’s multiple comparison posttests following one-way ANOVA) and (C) viable cell density (*P<0.05, **P<0.01, or
***P<0.001 for comparison to UT-EC in Bonferroni posttests following two-way ANOVA). (D) Contribution of lytic death to the lower cell density with rKSHV.219 inoculation
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ninfected cells. To address this question, untreated cells, labelled
ith DDAO-SE were co-cultured with non-labelled, rKSHV.219-
noculated cells from the same donor. This co-culture was for 5
ays and was established either immediately following inocula-
ion (0dpi, following removal of free virus) or 3dpi. Results were
nalysed using ﬂow cytometry at the beginning and end of the co-
ulture period (Fig. 4A), allowing determination of the acquisition
f GFP-positivity by untreated DDAO-SE positive cells co-cultured
ith rKSHV.219-inoculated endothelial cells (Fig. 4A). The DDAO-
E staining faded during the period of co-culture but remained
dequate in intensity for labelled cells to be distinguished from
on-labelled cells. There was low, but consistently detectable,
ransmission of GFP to untreatedDDAO-SE positive non-inoculated
ndothelial cells, bothwhen co-cultures were established immedi-
tely following inoculation and, to a lesser extent,when co-cultures
ere established at 3dpi (Fig. 4B). This was consistent with earlier
ata, which showed that the number of RFP-positive cells peaked
arly after inoculation (Fig. 3B); therefore, presumably there was
ore rKSHV.219 being produced and capable of re-infection in the
o-cultures established early after infection. However, horizontal
ransmission did not account for the increase inGFP-positivity seen
n the rKSHV.219-inoculated cultures over time (Fig. 3A), as 35% of
FP-negative DDAO-SE negative cells from the original rKSHV.219-
noculated cultures acquired GFP expression between 3 and 8dpi,HV.219-EC (plotted cumulatively), and total (lytic + viable) cell number enumerated
tests following two-way ANOVA). Data are mean± SEM for 3–4 experiments.
in contrast to only 3.3% of DDAO-SE positive non-inoculated
endothelial cells by horizontal transmission (Fig. 4C).
3.4. Analysis of the temporal relationship between rKSHV.219
GFP and LANA-1-expression
As the increase in percentage GFP-positive cells within
rKSHV.219-inoculated cultures over time could not be explained by
an increased proliferative capability of infected cells, or transmis-
sion of infection between cells, this studywent on to investigate the
possibility that the total number of GFP-positive cells seen at 10dpi
was establishedduring initial inoculation, and the time required for
intracellular ampliﬁcation of the GFP signal varied between indi-
vidual cells. rKSHV.219-inoculated cultures were stained, at either
24h or 10dpi, with an antibody against KSHV latency-associated
antigen-1 (LANA-1), as an alternative conﬁrmation of infection.
LANA-1 stained with a distinct punctate nuclear pattern as previ-
ously described (Kedes et al., 1997; Fig. 5A). Previous studies have
shown the number of individual LANA-1 dots to be directly propor-
tional to the amount of intracellular viral DNA (Adang et al., 2006).
At 24hpi all GFP-positive cells stained positive for one or more
LANA-1 dots (Fig. 5A). Interestingly, however, LANA-1 dots were
also detected in 37% of GFP-negative cells within the rKSHV219-
incolculated culture at that time point (Fig. 5A and B), although the
256 H.C. Jeffery et al. / Journal of Virological Methods 193 (2013) 251–259
Fig. 4. Quantiﬁcation of horizontal transmission of rKSHV.219 infection through inoculated endothelial cell cultures. Endothelial cells were inoculated with rKSHV.219 (MOI
10) and maintained in culture for 0 or 3 days before they were mixed with DDAO-SE-labelled untreated endothelial cells (UT-EC) and co-cultured for 5 days. Proportions of
DDAO-SE positive UT-EC or GFP-negative, DDAO-SE negative cells that acquired GFP-positivity by the end of the 5d culture period were assessed to detemine rKSHV.219
re-infection. (A) GFP Log v DDAO-SE Log plots for a representative assay ﬁxed at the start and end of the 5 day co-culture period. In the assay, single population controls
including: non-labelled UT-EC; DDAO-SE-labelled UT-EC; and non-labelled rKSHV.219-EC, as well as a co-culture control of non-labelled UT-EC and DDAO-SE-labelled UT-EC,
were established in parallel to verify that double positive cells were not due to dye transfer or to the positioning of the quadrants for analysis. (B and C) Quantiﬁcation of the
data illustrated in (A) showing: (B) the percentage of DDAO-SE positive UT-EC that became GFP-positive during the 5 day co-culture for cultures established immediately
a o uni
D hed 3
n
G
1
p
G
i
i
a
b
a
i
(
t
O
a
d
t
F
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DAO-SE negative rKSHV.219-EC) during the 5 day co-culture, for cultures establis
umber of dots per cellwas signiﬁcantly lower than that seen in the
FP-positive group. At 10dpi 98% of GFP-positive cells were LANA-
positive (Fig. 5C), and only 12% of GFP-negative cellswere LANA-1
ositive. These data suggested that the temporal development of
FP-positivity was related to initial viral load. To investigate this
dea further, cellswere grouped according to theirGFPﬂuorescence
ntensity into the categories negative, weak, medium or bright. An
ssociation between the intensity of GFP expression and the num-
er of LANA-1 dots was evident at both 24hpi and 10dpi (Fig. 5D
nd E). Interestingly, the overall number of LANA-1 dots in each
nfected cell was signiﬁcantly lower at 10dpi compared to 24hpi
P<0.0001 by unpaired t-test). Cells were also less bright at 10dpi
han 24h, possibly this indicated a loss of viral episomes over time.
verall these data support further the hypothesis that time for
mpliﬁcation of viral copy number and/or GFP accumulation to
etectable levels in cells that receive a lower viral load accounts for
he delay in GFP-positivity observed in this system. Taken together,
ig. 5D and E indicates that viral gene expression, yielding 5–10
ANA-1 dots, is the threshold for GFP-positivity in this system.nfected cell populations within the co-culture (either DDAO-SE positive UT-EC or
dpi. Data are mean± SEM for 2–3 experiments.
4. Discussion
The development of a recombinant KSHV (rKSHV.219) that
has been engineered to express GFP or RFP, indicating latent or
lytic infection respectively, has provided an extremely useful tool
to the KSHV research community. This study provides a detailed
description of the infection and transmission dynamics of this
virus in primary endothelial cells and discusses the validity of GFP
as a marker of infection of these cells using primary umbilical
vein endothelial cells as the model endothelial cell type. Initial
rKSHV.219 MOI and monolayer density modulated the resultant
percentage of GFP-positive cells. The percentage of GFP-positive
cells in rKSHV.219-inoculated cultures increased over time, whilst
the number of RFP-positive cells peaked at 2dpi. This lytic burst
did not lead to substantial transmission of newly produced virus to
uninfected cells. Indeed, the temporal increase in the percentage
of GFP-positive cells was related to the number of rKSHV.219
copies acquired per cell during initial inoculation. This study
also identiﬁes that GFP is not a reliable indicator of rKSHV.219
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Fig. 5. Comparison of LANA-1 and GFP as markers of rKSHV.219 infection of endothelial cells. Endothelial cells were inoculated with rKSHV.219 (MOI 10) and maintained in
culture prior to staining for, and quantiﬁcation of, the number of LANA-1 dots in GFP-negative or GFP-positive cells at (B) 24hpi, or (C) 10dpi (***P<0.001 by unpaired t-test).
(A) Representative image of a KSHV-inoculated endothelial cell culture stained for LANA-1 at 24h. Arrows indicate GFP-negative, LANA-1 positive cells. GFP Frequency of
LANA-1 dots versus GFP intensity at (C) 24hpi or (D) 10dpi. ANOVA showed a signiﬁcant effect of GFP intensity on LANA-1 dot frequency (P<0.0001).
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Grundhoff, A., Ganem, D., 2004. Inefﬁcient establishment of KSHV latency suggests
anadditional role for continued lytic replication inKaposi sarcomapathogenesis.
J. Clin. Invest. 113, 124–136.
Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., Pollok, K.,
Ferkowicz, M.J., Gilley, D., Yoder, M.C., 2004. Identiﬁcation of a novel hierarchy58 H.C. Jeffery et al. / Journal of Viro
nfection of endothelial cells at early time points post-inoculation,
s GFP-negative cells within rKSHV.219-inoculated cultures were
requently LANA-1-positive.However, by10dpi therewas agreater
oncordance between GFP and LANA-1 expression, revealing that
FP was a reliable indicator for rKSHV.219 infection at later time
oints. Overall, this report not only provides useful and important
nformation for researchers using rKSHV.219 to infect primary
ndothelial cells, but also raises important factors to considerwhen
onducting researchwithviruses engineered to expressﬂuorescent
roteins from cellular promoters as a marker of infection.
The temporal increase in the percentage of GFP-positive cells
ithin rKSHV.219-inoculated cultures, which this study identiﬁed,
as consistentwithprevious reports onKSHV infectionof endothe-
ial cells (Butler et al., 2011; Moses et al., 1999). Others suggested
hat such an increase could be a consequence of an enhancedprolif-
ration of infected cells, or horizontal transmission of KSHV virions
Moses et al., 1999). However, in this system, rKSHV.219 did not
ncrease endothelial cell proliferation; indeed, cell numbers were
onsistently lower in the rKSHV.219-inoculated cultures than in
he untreated control cultures, a phenomenon that was mostly
xplained by the death of infected cells from lytic replication. Sec-
ndly, theoccurrenceofhorizontal transmissionof rKSHV.219 from
nfected to untreated cells was minimal, and signiﬁcantly (indeed,
ver 10 times) lower than the increase in GFP-positive endothelial
ells arising in rKSHV.219-inoculated cultures over time. Thus it
ppeared that in this system, the increase in the percentage of GFP-
ositive cells over timewas a consequence of non-uniform loading
f the endothelial cells with rKSHV.219 virions during the initial
noculation, meaning that where fewer viral copies were originally
elivered to the cells, there was a longer delay before detectable
evels of GFP could be identiﬁed using the methods stated. Previ-
us studies have reported that de novo infection with KSHV can
esult in highly varied levels of intracellular KSHV load, which cor-
elate with both the total LANA-1 ﬂuorescence intensity and the
umber of LANA-1 dots (Adang et al., 2006). Why LANA-1 expres-
ion is higher in some cells than others has not been described, but
ne speculation is that it could be due to variation between indi-
idual cells within the culture. For example, the cell cycle status of
cell could affect its propensity for infection, as has been described
or papillomavirus (Pyeon et al., 2009). Previous work has shown
hat endothelial cells isolated fromumbilical cords contain amixed
opulation, with both mature and progenitor endothelial cells in
he resultant culture (Ingram et al., 2004); therefore intra-culture
ariation in the expression of molecules required for KSHV entry
r LANA-1 expressionmight also be involved. In this study, LANA-1
as found expressed at low levels in almost 40% of GFP-negative
ells at 24hr following rKSHV.219-inoculation. Those cells that had
higher viral load (i.e. a higher frequency of LANA-1 dots) were
ore likely to be GFP-positive at this early time point. At 10dpi,
FP expression correlatedmore closelywith the presence of LANA-
, although interestingly, the average number of LANA-1 dots per
ell was lower at this later time point, suggesting loss of episomes
ith culture duration, consistentwith previous reports in other cell
ypes (Grundhoff and Ganem, 2004). The intensity of GFP signal at
his later time point may not be an accurate measure of episome
umber itself, due to the dynamics of episome loss vs. GFP loss over
ime. Thus, for a conclusive assessment of the presence and quan-
ity of rKSHV.219 in each cell it would be necessary to stain for a
iral protein, such as LANA-1. In addition, qRT-PCR could help to
rovide a more deﬁnitive measurement of episome number and
bsolute viral load in the culture.
Whether it is important to consider the LANA-1 positive, GFP
egative, cells within the culture when studying the functional
onsequences of infection is so far unknown. Qualitative assess-
ents of cell shape and GFP expression at 24hpi in this study
oncluded that cells with the strongest GFP expression underwentl Methods 193 (2013) 251–259
the greatest morphological change. Furthermore, previous work
showed that the reduction of ICAM-1 expression on rKSHV.219-
inoculated endothelial cells was more pronounced for the highly
GFP-positive cells, compared to those that expressed less GFP
(Butler et al., 2011). Thus, it is likely that varying thresholdsof virion
number are required to modify KSHV-induced cellular processes
within a deﬁned time frame.However, itmight be assumed that the
presence of even a single virion in the cell could modify its pheno-
typewhen compared to an uninfected cell; therefore GFP-negative,
LANA-1-positive cells cannot be assumed equivalent to untreated
cells, and further studies are required to establish the relationships
linking GFP expression, number of LANA-1 dots and function.
In conclusion, this study provides a useful characterisation of
rKSHV.219 infection of primary endothelial cells. In addition, it
raises important points to be considered when using GFP expres-
sion as a deﬁnitive marker of rKSHV.219 infection.
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